Listed

Processa Pharmaceuticals, Inc.

PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Processa Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2022-11-0816:06 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-030942
2022-11-0411:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-030427
2022-09-0721:46 ET8-K7.01 Regulation FD disclosure0001493152-22-025171
2022-08-1210:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-022220
2022-08-1116:01 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-022063
2022-08-0409:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-021259
2022-07-2516:48 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-020258
2022-07-1415:51 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-22-019301
2022-05-3108:00 ETDEF 14AProxy statementPeriod 2022-05-310001493152-22-015428
2022-05-1617:20 ET8-K8.01 Other events0001493152-22-013963
2022-05-1216:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-013045
2022-05-1216:16 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013040
2022-05-0215:55 ET10-K/AAnnual report, amendedPeriod 2021-12-310001493152-22-011777
2022-03-3016:06 ET10-KAnnual reportPeriod 2021-12-310001493152-22-008156
2022-03-2416:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-007680
2022-03-1708:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-007101
2022-01-2608:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-002239
2022-01-0614:36 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-22-000543
2021-11-1206:05 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-027929
2021-11-0513:59 ET8-K5.07 Shareholder vote results0001493152-21-027320
2021-09-2014:51 ETDEF 14AProxy statementPeriod 2021-09-200001493152-21-023145
2021-09-2008:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-023107
2021-08-2016:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-21-020817
2021-08-1306:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-019582
2021-08-1216:01 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-019495
2021-07-3018:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-018127
2021-07-1509:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-016906
2021-06-1711:35 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-014623
2021-06-1017:30 ET8-K5.07 Shareholder vote results0001493152-21-014058
2021-06-0913:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-013879
2021-05-2606:15 ET8-K1.02 Termination of a material agreement0001493152-21-012907
2021-05-2016:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-012350
2021-05-1317:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-011353
2021-05-1316:30 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-011311
2021-04-2214:00 ETDEF 14AProxy statementPeriod 2021-04-220001493152-21-009443
2021-04-0716:23 ET10-K/AAnnual report, amendedPeriod 2020-12-310001493152-21-008210
2021-03-2516:15 ET10-KAnnual reportPeriod 2020-12-310001493152-21-006807
2021-03-2516:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-006793
2021-02-1810:08 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-004218
2021-01-1113:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-000718
2020-11-1216:01 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-021083
2020-11-0509:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-020540
2020-10-1310:08 ETSC 13DOwnership report, active investor0000897069-20-000396
2020-10-1309:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-019301
2020-10-0616:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-019018
2020-09-3016:06 ETS-1/ARegistration statement, amended0001493152-20-018617
2020-09-1719:38 ETS-1/ARegistration statement, amended0001493152-20-017927
2020-08-2709:30 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-016815
2020-08-2009:30 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-016387
2020-08-0515:32 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-014712

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.